Tag: fsma

Feb 18
Press release on the reopening of trading in Fagron

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Fagron, ISIN BE0003874915, on Euronext Brussels is reopened from 03/07/2019 at 09:00 CET following the publication of a press release. Source: FSMA

Feb 18
Press release on the suspension of trading in Fagron

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Fagron, ISIN BE0003874915, on Euronext Brussels is suspended on the request of the company from 02/07/2019 at 15:23 CET until the publication of a press release. Source: FSMA

Feb 18
Press release on the reopening of trading in Bone Therapeutics

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of BONE THERAPEUTICS, ISIN BE0974280126 on Euronext Brussels will re-open on 28/06/2019 at 09:00 CET. Source: FSMA

Feb 18
Adequate organizational framework for the combat against money laundering and terrorist financing

In its circular FSMA_2019_12 (French – Dutch) the FSMA establishes measures for the application of the provisions regarding organization and internal control contained in the Law of 18 September 2017 on the prevention of money laundering and terrorist financing and on the restriction of the use of cash. The FSMA also clarifies its expectations regarding […]

Feb 18
Press release on the reopening of trading in Retail Estates

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Retail Estates, ISIN BE0003720340 on Euronext Brussels will re-open on 27/06/2019 at 9:00 CET. Source: FSMA

Feb 18
Press release on the suspension of trading in Bone Therapeutics

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Bone Therapeutics, ISIN BE0974280126, on Euronext Brussels is suspended from 27/06/2019 at 09:00 CET until the publication of a press release. Source: FSMA

Feb 18
Press release on the reopening of trading in Fagron

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Fagron, ISIN BE0003874915 on Euronext Brussels will re-open on 26/06/2019 at 15:45 CET. Source: FSMA

Feb 17
Mandatory public takeover bid by Quvadec NV on Resilux NV

This press release is not available in English. Please consult the French or Dutch site. Source: FSMA

Feb 17
Go Capital FX

The Financial Services and Markets Authority (FSMA) warns the public against the activities of Go Capital FX (Go Capital 123 – Lancelot Equity Ltd.), a company that offers binary options without complying with Belgian financial legislation. Go Capital FX (Go Capital 123 – Lancelot Equity Ltd.) is not allowed to provide banking and/or investment services […]

Feb 17
Vipwayzone

The Financial Services and Markets Authority (FSMA) warns the public against the activities of Vipwayzone, a company that offers binary options without complying with Belgian financial legislation. Vipwayzone is not allowed to provide banking and/or investment services in or from Belgium. Furthermore, the FSMA reminds the public that since 18 August 2016, no investment firm […]